- SID Score
- 7.0/10
- Fair value
- $320.98
- Generated
- Sep 25, 2026
- Model
- claude-haiku-4-5-20251001
JPMorgan Chase & Co. trades at $338.56 with a market capitalization of $863.9 billion, positioning it as a dominant player in financial services. The stock exhibits a moderate valuation with a P/E ratio of 15.25, suggesting reasonable pricing relative to earnings, though the fair value estimate of $320.98 implies potential downside of 8.2% from current levels. The company's SID Score of 7.0/10 indicates decent overall quality, though factor grades across Value, Growth, Profitability, Momentum, and Dividends all register at C-level, suggesting balanced but unexceptional performance across key metrics.
JPMorgan's recent earnings have demonstrated resilience, with Q2 2026 EPS of $6.14 beating estimates of $5.59 and Q1 2026 EPS of $5.94 exceeding expectations of $5.49, indicating consistent operational execution. The company's annualized earnings run rate of approximately $23.76 per share (based on recent quarterly performance) supports the current valuation, though the C-grade profitability rating suggests margins may face pressure or lack significant expansion. The extremely low dividend yield of 0.02% is notably concerning for income-focused investors, indicating JPMorgan prioritizes capital allocation toward share buybacks or retained earnings rather than shareholder distributions.
The RSI(14) reading of 31.0 signals an oversold condition, suggesting potential technical support and possible mean reversion opportunity in the near term. The stock currently trades below its 50-day moving average of $353.51 but above the 200-day moving average of $318.56, indicating a mild downtrend within a longer-term uptrend that maintains technical support around the $318 level. This configuration presents a mixed technical picture where short-term weakness exists, yet the stock maintains structural support from longer-term moving averages.
Analyst & Insider Sentiment
The analyst consensus remains "Buy" with an average price target of $322.13, which aligns closely with the fair value estimate of $320.98, though both figures represent downside from the current $338.56 price. Recent insider activity reveals predominantly bearish positioning, with notable sells including Douglas B. Petno's 223,755 shares on July 24, 2026, and Stacey Friedman's 40,795 shares on July 27, 2026, contrasting with limited buying activity represented by Virginia M. Rometty's 15,032 share purchase on June 30, 2026. The disparity between sell volume and buy volume among insiders suggests management may view current valuations as stretched relative to intrinsic value.
JPMorgan faces cyclical risks inherent to financial services, including sensitivity to interest rate changes, credit quality deterioration, and potential economic slowdown that could pressure net interest margins and loan growth. The neutral news sentiment and absence of recent major catalysts suggest limited near-term catalysts for significant price movement, while the C-grade momentum rating indicates the stock lacks positive directional bias. Additionally, the insider selling pattern warrants monitoring as a potential warning signal regarding management's confidence in current valuations and near-term prospects.
JPMorgan Chase presents a cautiously neutral investment opportunity characterized by solid fundamental earnings performance and analyst support, yet tempered by technical weakness and insider selling pressure. The stock's 8.2% downside to fair value combined with the oversold RSI(14) of 31.0 suggests tactical patience may be warranted before initiating new positions, as current risk-reward dynamics favor waiting for confirmation of stabilization near the $318-$322 support zone. Value-oriented investors seeking exposure to financial services may find JPMorgan attractive on further weakness, while the minimal dividend yield makes it unsuitable for income-focused portfolios.
